Gremlin 2 inhibits adipocyte differentiation through activation of Wnt/β-catenin signaling

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 5891-5896

  Wu, Qing ^a   Tang, Shi Guo ^b   Yuan, Zhong Ming ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Ninth People's Hospital   (China)

Author keywords

Adipocyte differentiation; Adipogenesis; Gremlin2; Wnt catenin signaling

Indexed keywords

BETA CATENIN; GLYCOPROTEIN; GREMLIN 2; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN; GREM2 PROTEIN, MOUSE; PROTEIN;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CODING; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; RETROVIRIDAE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SUBCUTANEOUS FAT; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICE; OBESITY; PROTEINS; WNT SIGNALING PATHWAY;

EID: 84940515368     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4117     Document Type: Article

References (23)

1. Rueda-Clausen CF, Padwal RS and Sharma AM: New pharmacological approaches for obesity management. Nat Rev Endocrinol 9: 467-478, 2013.
2. Fenske W, Athanasiou T, Harling L, Drechsler C, Darzi A and Ashafan H: Obesity-related cardiorenal disease: the benefts of bariatric surgery. Nat Rev Nephol 9: 539-551, 2013.
3. Tao W and Lagergren J: Clinical management of obese patients with cancer. Nat Rev Clin Oncol 10: 519-533, 2013.
4. Rosen ED and MacDougald OA: Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896, 2006.
5. Kawai M and Rosen CJ: PPARy: A circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6: 629-636, 2010.
6. Cristancho AG and Lazar MA: Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12: 722-734, 2011.
7. Oishi Y, Manabe I, Tobe K, et al: Kruppel-like transcription factor klf5 is a key regulator of adipocyte differentiation. Cell Metab 1: 27-39, 2005.
8. Birsoy K, Chen Z and Friedman J: Transcriptional regulation of adipogenesis by klf4. Cell Metab 7: 339-347, 2008.
9. Choi JH, Banks AS, Estall JL, et al: Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by cdk5. Nature 466: 451-456, 2010.
10. Qiang L, Wang L, Kon N, et al: Brown remodeling of white adipose tissue by sirt1-dependent deacetylation of ppargamma. Cell 150: 620-632, 2012.
11. Dutchak PA, Katafuchi T, Bookout AL, et al: Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones. Cell 148: 556-567, 2012.
12. Zuniga E, Rippen M, Alexander C, Schilling TF and Crump JG: Gremlin 2 regulates distinct roles of bmp and endothelin 1 signaling in dorsoventral patterning of the facial skeleton. Development 138: 5147-5156, 2011.
13. Suzuki D, Yamada A, Aizawa R, et al: bmp2 differentially regulates the expression of gremlin1 and gremlin2, the negative regulators of bmp function, during osteoblast differentiation. Calcif Tissue Int 91: 88-96, 2012.
14. Muller II, Melville DB, Tanwar V, et al: Functional modeling in zebrafsh demonstrates that the atrial-fbrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm. Dis Models Mech 6: 332-341, 2013.
15. Paternoster L, Lorentzon M, Lehtimaki T, et al: Genetic determinants of trabecular and cortical volumetric bone mineral densities and bone microstructure. PLoS Genet 9: e1003247, 2013.
16. Macotela Y, Emanuelli B, Mori MA, et al: Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes 61: 1691-1699, 2012.
17. Takahashi A, Morita M, Yokoyama K, Suzuki T and Yamamoto T: Tob2 inhibits peroxisome proliferator-activated receptor gamma2 expression by sequestering smads and c/ebpalpha during adipocyte differentiation. Mol Cell Biol 32: 5067-5077, 2012.
18. Ross SE, Hemati N, Longo KA, et al: Inhibition of adipogenesis by wnt signaling. Science 289: 950-953, 2000.
19. Laudes M: Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol 46: R65-R72, 2011.
20. Prestwich TC and Macdougald OA: Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol 19: 612-617, 2007.
21. Wright WS, Longo KA, Dolinsky VW, et al: WNT10b inhibits obesity in ob/ob and agouti mice. Diabetes 56: 295-303, 2007.
22. Chistodoulides C, Scarda A, Granzotto M, et al: WNT10B mutations in human obesity. Diabetologia 49: 678-684, 2006.
23. Takada I, Kouzmenko AP and Kato S: Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5: 442-447, 2009.